This report is being filed due to endocarditis requiring treatment, unknown if device related.Patient id: (b)(6).It was reported that on (b)(6) 2021, the patient presented with functional mitral regurgitation (mr) grade 4+, with dilated cardiomyopathy.One mitraclip was implanted, reducing the mr to grade 1+.On (b)(6) 2022, the patient as admitted to the hospital with back, left shoulder and lower back pain.Infective endocarditis was diagnosed.Medications were provided and a blood transfusion was performed as treatment.The event resolved and the patient was discharged from the hospital.Per physician, the event was unknown if device related.There was no device malfunction.No additional information was provided regarding this issue.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported endocarditis was unable to be determined.The reported pain appears to be related to the reported endocarditis.The reported patient effect of endocarditis and pain, as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.The reported medication required, hospitalization, and unexpected medical intervention (blood transfusion) were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|